Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
45.47
-1.50 (-3.19%)
Oct 5, 2026, 4:00 PM EDT - Market closed
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $3.33 billion as of October 5, 2026. Its market cap has increased by 186.81% in one year.
Market Cap
3.33B
Enterprise Value
2.44B
1-Year Change
186.81%
Ranking
Category
Stock Price
$45.47
ChartMarket Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $3.33B, an increase of 242.05%. That is a compound annual growth rate of 40.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 3.33B | 264.53% |
| Dec 31, 2025 | 913.95M | -16.86% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
| Feb 24, 2023 | 974.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xenon Pharmaceuticals | 3.62B |
| IDEAYA Biosciences | 3.60B |
| Parabilis Medicines | 3.59B |
| Legend Biotech | 3.52B |
| Acadia Pharmaceuticals | 3.43B |
| Celcuity | 3.42B |
| Viking Therapeutics | 3.38B |
| Tarsus Pharmaceuticals | 3.24B |